Inter- and intra-combinatorial regulation by transcription factors and microRNAs

January 2007
BMC Genomics;2007, Vol. 8, p396
Academic Journal
No abstract available.


Related Articles

  • Regulation of Mesenchymal Phenotype by MicroRNAs in Cancer. Jinchun Yan; Gumireddy, Kiranmai; Anping Li; Qihong Huang // Current Cancer Drug Targets;Nov2013, Vol. 13 Issue 9, p930 

    Epithelial-mesenchymal transition (EMT) is a developmental process that converts epithelial cells into migratory and invasive cells. This process also plays an important role in cancer progression and metastasis by enabling tumor cells to leave primary sites. EMT is regulated by complex...

  • Regulation of Adipocyte Differentiation via MicroRNAs. You Hwa Son; Sojeong Ka; A. Young Kim; Jae Bum Kim // Endocrinology & Metabolism;Jun2014, Vol. 29 Issue 2, p122 

    Adipocyte differentiation, termed adipogenesis, is a complicated process in which pluripotent mesenchymal stem cells differentiate into mature adipocytes. The process of adipocyte differentiation is tightly regulated by a number of transcription factors, hormones and signaling pathway molecules....

  • MicroRNA Gene Networks in Oncogenesis. Drakaki, Alexandra; Iliopoulos, Dimitrios // Current Genomics;Mar2009, Vol. 10 Issue 1, p35 

    MicroRNAs are small non-coding RNAs that regulate gene expression at the transcriptional or posttranscriptional level. They are involved in cellular development, differentiation, proliferation and apoptosis and play a significant role in cancer. Examination of tumor-specific microRNA expression...

  • MicroRNA signature of the human developing pancreas. Rosero, Samuel; Bravo-Egana, Valia; Zhijie Jiang; Khuri, Sawsan; Tsinoremas, Nicholas; Klein, Dagmar; Sabates, Eduardo; Correa-Medina, Mayrin; Ricordi, Camillo; Domínguez-Bendala, Juan; Diez, Juan; Pastori, Ricardo L. // BMC Genomics;2010, Vol. 11, p509 

    Background: MicroRNAs are non-coding RNAs that regulate gene expression including differentiation and development by either inhibiting translation or inducing target degradation. The aim of this study is to determine the microRNA expression signature during human pancreatic development and to...

  • Another piece in the p53 puzzle. Seton-Rogers, Sarah // Nature Reviews Cancer;Jul2007, Vol. 7 Issue 7, p488 

    The article presents a study related to tumor protein 53 (TP53), which is a transcription factor that regulates the cell cycle and functions as a tumor suppressor. Here, the researchers have shown that some of TP53's functions may be mediated through transcriptional activation of microRNAs (miRNAs).

  • P572 Pitx2 differently controls the expression of gene embedded microRNAs in cardiac and skeletal muscle cells. Hernandez-Torres, F; Aranega, AE; Franco, D // Cardiovascular Research;Jul2014, Vol. 103 Issue suppl_1, pS103 

    The Pitx2 gene is a member of the Bicoid-like homeobox family that plays an important role in embryonic left-right signalling and subsequently during cardiac and skeletal muscle organogenesis. Pitx2 misregulation has been as well associated with skeletal and cardiac muscle diseases. Although...

  • MicroRNAs as key regulators of xenobiotic biotransformation and drug response. Bolleyn, Jennifer; De Kock, Joery; Rodrigues, Robim; Vinken, Mathieu; Rogiers, Vera; Vanhaecke, Tamara // Archives of Toxicology;Sep2015, Vol. 89 Issue 9, p1523 

    In the last decade, microRNAs have emerged as key factors that negatively regulate mRNA expression. It has been estimated that more than 50 % of protein-coding genes are under microRNA control and each microRNA is predicted to repress several mRNA targets. In this respect, it is recognized that...

  • Insights Into the Role of microRNAs in Cardiac Diseases: From Biological Signalling to Therapeutic Targets. Zorio, E.; Medina, P.; Rueda, J.; Millán, J. M.; Arnau, M. A.; Beneyto, M.; Marín, F.; Gimeno, J. R.; Osca, J.; Salvador, A.; España, F.; Estellés, A. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2009, Vol. 7 Issue 1, p82 

    microRNAs have recently opened new pathways to explain gene expression and disease biology in many scenarios, including cardiac diseases. microRNAs are endogenous small non-coding RNAs that mediate post-transcriptional repression or messenger RNA degradation. By annealing to inexactly...

  • Transcription factor-microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome. HAI-YING LIU; YU-LING HUANG; JIAN-QIAO LIU; QING HUANG // Molecular Medicine Reports;2016, Vol. 13 Issue 5, p3920 

    Polycystic ovary syndrome (PCOS) is the most common type of endocrine disorder, affecting 5-11% of women of reproductive age worldwide. Transcription factors (TFs) and microRNAs are considered to have crucial roles in the developmental process of several diseases and have synergistic regulatory...

  • microRNAs, transforming growth factor beta-1 and tissue fibrosis. Jenkins, R. H. // Proceedings of the Physiological Society;2013, p192P 

    microRNAs are small, endogenous, post-transcriptional regulators of gene expression. A single microRNA may potentially regulate several hundred protein-coding genes, and recent estimates suggest approximately 60% of human protein-coding genes are regulated by microRNAs. Changes in microRNA...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics